Products containing titanium dioxide in the EU are no longer required to carry warnings about cancer risk, after the European Chemicals Agency (Echa) revoked its classification as a suspected carcinogen. The move follows a June 2025 decision by the Court of Justice of the European Union and means that safety data sheets, labelling and packaging requirements for titanium dioxide have been relaxed across industries including paints, pharmaceuticals, cosmetics and food.

The decision is the latest in a decade-long regulatory debate. In 2016, the French Agency for Food, Environmental and Occupational Health & Safety (ANSES) proposed that powdered titanium dioxide should be classified as an ‘inhalation carcinogen’. Echa’s Committee for Risk Assessment (RAC) supported the proposal in 2017, leading to the European Commission listing the substance as a category 2 suspected carcinogen. This required products containing powdered titanium dioxide to carry the warning ‘H351: suspected of causing cancer when inhaled’.

Multiple manufacturers, downstream users and importers have mounted legal challenges to that ruling. In November 2022, the General Court of the European Union ruled that the commission had committed a ‘manifest error’ in using scientific evidence but failing to demonstrate intrinsic carcinogenicity of titanium dioxide. After more appeals from France and the European Commission were dismissed in August 2025, the classification was finally revoked. As a result, titanium dioxide products are no longer required to carry the warning label.

As industries and authorities adjust to this change, Echa and industry experts will continue to monitor advances in this area.

Reference:

https://www.chemistryworld.com/news/titanium-dioxide-loses-eu-carcinogen-label-after-court-ruling/4022188.article

READ MORE
Exim rebrands as ExSyn: We celebrate our 30-year heritage with a new brand and website that bring alive our values and purpose
News · 27/03/2021

Today we announce that Exim is rebranding as ExSyn. We are presenting a new brand identity and website as a reflection of our relentless transformation over the course of 30 years serving the pharma and chemical industries. The new brand builds upon our core strengths as a sourcing company and captures our most essential duty: helping improve people’s health and lives.

In focus: Glyceryl Stearate Citrate
Products in focus · 25/11/2025

Glyceryl Stearate Citrate (GSC) is a plant-derived, biodegradable emulsifier commonly used in cosmetics and personal-care products. It functions primarily as an anionic oil-in-water (O/W) emulsifier, helping blend oils and water into smooth, stable creams and lotions. Its natural origin and gentle profile make it popular in eco-certified, organic, and sensitive-skin formulations.

In focus: DL-Serine
Products in focus · 18/11/2025

DL-Serine is a racemic mixture of both the D- and L-forms of the amino acid serine, which is a polar, nonessential amino acid. It  is an α-amino acid characterized by its hydroxyl-containing side chain, which enables it to take part in numerous biochemical reactions and synthetic processes. It functions as a pivotal intermediate in the biosynthesis of amino acids, including glycine and cysteine, underscoring its essential role in cellular metabolism. Moreover, it constitutes a critical pharmaceutical intermediate for the synthesis of a broad spectrum of therapeutic agents and drug candidates.

In focus: Ethyl Vinyl Ether (EVE)
Products in focus · 11/11/2025

Ethyl vinyl ether is a reactive, flammable, volatile liquid with a strong ether-like odor. Featuring two conjugated functional groups—an ether and an alkene—this molecule act as important building block, especially in polymer synthesis. Its applications span multiple industrial sectors, including semiconductors, coatings, inks, fragrances, adhesives, paints, oil viscosity modifiers and pharmaceuticals, with promising potential as a dietary supplement.